nvax fda news - Search News

FDA pauses Novavax's trial of combo COVID-flu shot

Seeking Alpha on MSN · 1d

Novavax stock plunges as FDA puts clinical hold on COVID-flu combo vaccine

Shares of Novavax (NASDAQ:NVAX) fell roughly 30% Wednesday morning after the U.S. FDA put a clinical hold on the new drug application of its COVID-19 and influenza combination vaccine and standalone influenza vaccine candidates,

US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns

The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company said on Wednesday.

YAHOO!Finance · 1d

FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves

Novavax Inc. (NASDAQ:NVAX) stock is trading lower on Wednesday. The FDA has placed a clinical hold on Novavax’s Investigational New Drug (IND) application for its COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates.

Zacks.com on MSN1h

Biotech Stock Roundup: VNDA, JAZZ Up on Updates, NVAX Suffers Setback & More

Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was ...

2h

Novavax’s Regulatory Setback and Mid-Term Underperformance: An Analyst’s Perspective

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.

3h

Novavax Stock Falls Nearly 20% After Clinical Trial Halted

Shares of American pharmaceutical company Novavax (NVAX) fell 19% on reports that the U.S. Food and Drug Administration (FDA) ...

SchaeffersResearch.com22h

3 Vaccine Stocks to Watch as Flu Season Approaches

Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring. Earlier today, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results